JP2016523925A5 - - Google Patents

Download PDF

Info

Publication number
JP2016523925A5
JP2016523925A5 JP2016524326A JP2016524326A JP2016523925A5 JP 2016523925 A5 JP2016523925 A5 JP 2016523925A5 JP 2016524326 A JP2016524326 A JP 2016524326A JP 2016524326 A JP2016524326 A JP 2016524326A JP 2016523925 A5 JP2016523925 A5 JP 2016523925A5
Authority
JP
Japan
Prior art keywords
amino
carbonyl
methylsulfamate
pyrimidin
pyrazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016524326A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016523925A (ja
JP6378759B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/045129 external-priority patent/WO2015002994A2/en
Publication of JP2016523925A publication Critical patent/JP2016523925A/ja
Publication of JP2016523925A5 publication Critical patent/JP2016523925A5/ja
Application granted granted Critical
Publication of JP6378759B2 publication Critical patent/JP6378759B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016524326A 2013-07-02 2014-07-01 Sumo活性化酵素阻害剤として有用なヘテロアリール化合物 Expired - Fee Related JP6378759B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361842097P 2013-07-02 2013-07-02
US61/842,097 2013-07-02
PCT/US2014/045129 WO2015002994A2 (en) 2013-07-02 2014-07-01 Heteroaryl compounds useful as inhibitors of sumo activating enzyme

Publications (3)

Publication Number Publication Date
JP2016523925A JP2016523925A (ja) 2016-08-12
JP2016523925A5 true JP2016523925A5 (enExample) 2017-08-10
JP6378759B2 JP6378759B2 (ja) 2018-08-22

Family

ID=52144279

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016524326A Expired - Fee Related JP6378759B2 (ja) 2013-07-02 2014-07-01 Sumo活性化酵素阻害剤として有用なヘテロアリール化合物

Country Status (8)

Country Link
US (1) US9695154B2 (enExample)
EP (1) EP3016934B1 (enExample)
JP (1) JP6378759B2 (enExample)
CN (1) CN105492429A (enExample)
BR (1) BR112015032902A8 (enExample)
CA (1) CA2916468C (enExample)
EA (1) EA032577B1 (enExample)
WO (1) WO2015002994A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008307B2 (en) 2006-08-08 2011-08-30 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of E1 activating enzymes
GEP201706687B (en) 2012-02-17 2017-06-26 Millennium Pharmaceuticals Inc (A Delaware Corporation) Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
CN104684559A (zh) 2012-08-03 2015-06-03 米伦纽姆医药公司 针对Uba6的吲哚取代的吡咯并嘧啶基抑制剂
EP3016934B1 (en) 2013-07-02 2018-01-10 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of sumo activating enzyme
KR102491125B1 (ko) 2014-07-01 2023-01-20 다케다 야쿠힌 고교 가부시키가이샤 Sumo 활성화 효소의 억제제로서 유용한 헤테로아릴 화합물
WO2017183927A1 (ko) * 2016-04-20 2017-10-26 한국화학연구원 신규한 헤테로고리 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물
CN105670066A (zh) * 2016-04-22 2016-06-15 宁波硫华聚合物有限公司 橡胶促进剂活性剂氧化镁母胶粒及其制备方法
CN107586315B (zh) * 2016-07-08 2020-03-31 成都海创药业有限公司 一种嵌合分子
EP3490980A4 (en) * 2016-07-22 2020-04-15 Virginia Commonwealth University Prodrug and protected forms of 5-hydroxymethylfurfuranal (5-hmf) and its derivatives
WO2020014139A1 (en) 2018-07-09 2020-01-16 Millennium Pharmaceuticals, Inc. Administration of sumo-activating enzyme inhibitor and anti-cd20 antibodies
WO2020023846A1 (en) 2018-07-27 2020-01-30 Arcus Biosciences, Inc. Pyridone a2r antagonists
US11578079B2 (en) 2018-07-31 2023-02-14 City Of Hope SUMO inhibitor compounds and uses thereof
MX2021010176A (es) 2019-02-27 2021-12-10 Takeda Pharmaceuticals Co Inhibidor de enzimas activadoras de sumo e inhibidores de punto de control.
US20250042850A1 (en) * 2021-01-25 2025-02-06 Athos Therapeutics, Inc. Pharmaceutical compounds and methods of making and using the same
WO2023073645A1 (en) 2021-10-29 2023-05-04 Takeda Pharmaceutical Company Limited Therapy comprising anti-cd19 antibody and sumo-activating enzyme inhibitor
EP4596557A1 (en) * 2022-09-30 2025-08-06 Wigen Biomedicine Technology (Shanghai) Co., Ltd. Compound as inhibitor for sumo activating enzyme
WO2024097736A1 (en) * 2022-11-02 2024-05-10 Arcus Biosciences, Inc. Processes for preparing azolopyrimidine compounds
WO2024099438A1 (zh) * 2022-11-11 2024-05-16 微境生物医药科技(上海)有限公司 作为sumo活化酶抑制剂的化合物
CN116640068A (zh) * 2023-05-26 2023-08-25 康化(上海)新药研发有限公司 一种(3-环丙基-2-炔-1-基)甘氨酸苄酯的合成方法

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194446A (en) 1989-06-12 1993-03-16 A. H. Robins Company, Incorporated Compounds having one or more aminosulfaonyloxy radicals useful as pharmaceuticals
AU6500696A (en) 1995-07-28 1997-02-26 Cubist Pharmaceuticals, Inc. Aminoacyl adenylate mimics as novel antimicrobial and antiparasitic agents
EP1485396A2 (en) 2002-02-28 2004-12-15 Biota, Inc. Nucleoside 5'-monophosphate mimics and their prodrugs
WO2004009610A2 (en) 2002-07-24 2004-01-29 Ptc Therapeutics, Inc. Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases
US7291603B2 (en) 2002-07-24 2007-11-06 Ptc Therapeutics, Inc. Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations
US7196092B2 (en) 2002-09-04 2007-03-27 Schering Corporation N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
NZ539162A (en) 2002-09-04 2006-07-28 Schering Corp Pyrazolopyrimidines as cyclin dependent kinase inhibitors
US7563798B2 (en) 2002-09-04 2009-07-21 Schering Corporation Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
ATE362474T1 (de) 2002-09-04 2007-06-15 Schering Corp Pyrazolo(1,5-a)pyrimidine als hemmstoffe cyclin- abhängiger kinasen
US20060276520A1 (en) 2002-11-13 2006-12-07 Rigel Pharmaceuticals, Inc. Rhodanine derivatives and pharmaceutical compositions containing them
WO2004087707A1 (en) 2003-03-31 2004-10-14 Vernalis (Cambridge) Limited Pyrazolopyrimidine compounds and their use in medicine
JP2005008581A (ja) 2003-06-20 2005-01-13 Kissei Pharmaceut Co Ltd 新規なピラゾロ[1,5−a]ピリミジン誘導体、それを含有する医薬組成物およびそれらの用途
WO2005037845A1 (en) 2003-10-17 2005-04-28 Rigel Pharmaceuticals, Inc. Benzothiazole and thiazole[5,5-b] pyridine compositions and their use as ubiquitin ligase inhibitors
US20070105890A1 (en) 2003-11-26 2007-05-10 Dainippon Sumitomo Pharma Co., Ltd Novel condensed imidazole derivative
US20050282818A1 (en) 2004-06-22 2005-12-22 Rigel Pharmaceuticals, Inc. Ubiquitin ligase inhibitors
CA2596424C (en) 2005-02-04 2016-03-29 Millennium Pharmaceuticals, Inc. Inhibitors of e1 activating enzymes
AR055206A1 (es) 2005-10-06 2007-08-08 Schering Corp Pirazolo[1, 5 - a]pirimidinas como inhibidoras de proteina quinasa, composiciones farmaceuticas y combinaciones con agentes citostaticos que las comprenden y su uso en la fabricacion de un medicamento para el tratamiento del cancer.
PT1989206E (pt) 2006-02-02 2012-10-15 Millennium Pharm Inc Inibidores da enzima de ativação e1
US8008307B2 (en) 2006-08-08 2011-08-30 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of E1 activating enzymes
EP2049491B1 (en) * 2006-08-08 2010-10-20 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of e1 activating enzymes
ES2602615T3 (es) 2007-06-12 2017-02-21 Achaogen, Inc. Agentes antibacterianos
US9216983B2 (en) 2007-12-21 2015-12-22 Board Of Regents, University Of Texas System Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity
ES2439009T3 (es) 2008-08-20 2014-01-21 Merck Sharp & Dohme Corp. Derivados de piridina y pirimidina sustituidos con etenilo y su uso en el tratamiento de infecciones virales
EP2331511A1 (en) 2008-08-20 2011-06-15 Schering Corporation Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
CA2734486A1 (en) 2008-08-20 2010-02-25 Southern Research Institute Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
CA2734488A1 (en) 2008-08-20 2010-02-25 Southern Research Institute Azo-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
EP3587434A1 (en) 2008-09-23 2020-01-01 Alnylam Pharmaceuticals Inc. Chemical modifications of monomers and oligonucleotides with click components for conjugation with ligands
WO2010086040A1 (en) 2009-01-29 2010-08-05 Biomarin Iga, Ltd. Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy
WO2010088518A2 (en) 2009-01-31 2010-08-05 Kalypsys, Inc. Heterocyclic modulators of gpr119 for treatment of disease
NZ596470A (en) 2009-05-14 2014-04-30 Millennium Pharm Inc Hydrochloride salt of ((1s,2s,4r)-4-{ 4-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-7h-pyrrolo [2,3-d]pyrimidin-7-yl} -2-hydroxycyclopentyl)methyl sulfamate
BR112012003637A2 (pt) 2009-08-17 2017-04-25 Memorial Sloan Kettering Cancer Center "compostos de ligação de proteína de choque térmico, composições, e métodos para preparar e usar os mesmos"
WO2011100131A2 (en) 2010-01-28 2011-08-18 Alnylam Pharmacuticals, Inc. Monomers and oligonucleotides comprising cycloaddition adduct(s)
WO2011103441A1 (en) 2010-02-18 2011-08-25 Schering Corporation Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
AU2010347233B2 (en) 2010-03-01 2015-06-18 Oncternal Therapeutics, Inc. Compounds for treatment of cancer
CA2806341C (en) 2010-07-29 2020-03-24 Rigel Pharmaceuticals, Inc. Ampk-activating heterocyclic compounds and methods for using the same
US20120077814A1 (en) 2010-09-10 2012-03-29 Zhong Wang Sulfonamide, sulfamate, and sulfamothioate derivatives
UA114894C2 (uk) * 2011-08-24 2017-08-28 Мілленніум Фармасьютікалз, Інк. Інгібітори nedd8-активуючого ферменту
WO2013052814A2 (en) * 2011-10-07 2013-04-11 Millennium Pharmaceuticals, Inc. E1 enzyme mutants and uses thereof
WO2013066729A1 (en) 2011-10-31 2013-05-10 Merck Sharp & Dohme Corp. Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
GEP201706687B (en) 2012-02-17 2017-06-26 Millennium Pharmaceuticals Inc (A Delaware Corporation) Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
US20150057243A1 (en) 2012-04-02 2015-02-26 Northern University Compositions and Methods for the Inhibition of Methyltransferases
EP3016934B1 (en) 2013-07-02 2018-01-10 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of sumo activating enzyme
US20150087673A1 (en) 2013-09-26 2015-03-26 Rigel Pharmaceuticals, Inc. Methods for using and biomarkers for ampk-activating compounds
CA2926207C (en) 2013-10-21 2022-06-21 Merck Patent Gmbh Heteroaryl compounds as btk inhibitors and uses thereof
WO2015110999A1 (en) 2014-01-24 2015-07-30 Piramal Enterprises Limited Ezh2 inhibitors and uses thereof

Similar Documents

Publication Publication Date Title
JP2016523925A5 (enExample)
JP2016523911A5 (enExample)
TWI327137B (enExample)
RU2015143517A (ru) Пиразолсодержащие соединения и их применения
JP6378759B2 (ja) Sumo活性化酵素阻害剤として有用なヘテロアリール化合物
TWI377910B (en) Hydrazide compound and pesticidal use of the same
HRP20230244T1 (hr) Derivati 3-(1-oksoizoindolin-2-il)piperidin-2,6-diona i njihova upotreba
JP2017502049A5 (enExample)
RU2021133444A (ru) Производные бензимидазола в качестве модуляторов ror-гамма
JP2010533158A5 (enExample)
RU2018145045A (ru) Соединения бензолсульфонамида и их применение в качестве терапевтических средств
JP2018520170A5 (enExample)
JP2011503166A5 (enExample)
CA2351725A1 (en) Substituted pyrazoles as p38 kinase inhibitors
RU2014110172A (ru) Гетероциклическое производное и фармацевтическое средство
JP2006503057A5 (enExample)
JP2015500332A5 (enExample)
JP2019516737A5 (enExample)
RU2016102137A (ru) Первичные карбоксамиды в качестве ингибиторов bik
HRP20230789T1 (hr) Derivati benzhidroksamske kiseline kao selektivni inhibitori hdac6
JP2013533868A5 (enExample)
JP2018530591A5 (enExample)
CA2670605A1 (en) Substituted arylpyrazoles
JP2011513221A5 (enExample)
RU2019113764A (ru) Соединения хиноксалина в качестве ингибиторов рецепторной тирозинкиназы iii типа